Buy or sell Akili Interactive Labs stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Akili Interactive Labs Stock

Akili builds clinically-validated cognitive therapeutics, assessments, and diagnostics that look and feel like video games.

Founded

2011

Notable Investors

Jazz Venture Partners

Headquarters

Boston MA, US

Total Funding

$128M

About Akili Interactive Labs Stock

Akili builds clinically-validated cognitive therapeutics, assessments, and diagnostics that look and feel like video games. It aims to develop a new type of electronic medicine that can be deployed remotely directly to any patient anywhere, prescribed and tracked by physicians, with the potential to be developed at a fraction of the cost of traditional medical approaches. Akili’s cognitive engine enables three separate clinical game versions for remote data-capture, with features designed for patient engagement. Its proprietary adaptive mechanics allow the software to automatically personalize to the patient’s ability level with no clinician input required. Akili is based in Boston, Massachusetts.

Investors

Funding History

January 2016$30.5M
July 2016$42.4M
May 2018$55.0M

Management

CEO

Eddie Martucci

Executive Creative Director

Matthew Omernick

Co-Founder

Adam Gazzaley

Executive Chairman

Robert Perez

Press

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 300K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo